comparemela.com
Latest Breaking News On - Sawa ito - Page 1 : comparemela.com
BlueSphere Bio Data to be Presented at the 2022 Joint ASTCT
PITTSBURGH, May 25, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform.
Bluesphere-bio
Sawa-ito
Andrew-mielach
Kim-jaffe
Business-development-operations
Company-contact
University-of-pittsburgh-school-medicine
High-throughput-cloning-reveals-diverse-properties
Lifesci-communications
Department-of-immunology
Hillman-cancer-center
Division-of-hematology
BlueSphere Bio Data to be Presented at the 2022 American
PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a revolutionary TCR discovery.
United-states
American
Bluesphere-bio
Sawa-ito
Andrew-mielach
Kim-jaffe
Business-development-operations
Company-contact
University-of-pittsburgh-school-medicine
Clinical-research-excluding-trials
American-association-for-cancer-research
Lifesci-communications
vimarsana © 2020. All Rights Reserved.